Improving imaging techniques for diagnosing and treating diabetic retinopathy
Official title: Robotic and handheld OCT imaging for diagnosis and treatment of diabetic retinopathy
Funded at Duke University · NIH-10996105 · Data updated 2026-11-12
This study is looking at new ways to take detailed pictures of the eye to help doctors find and treat diabetic retinopathy earlier and more easily, so patients can have better care without as many uncomfortable procedures.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | January 1, 2024 |
| Project end | December 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $41,373 |
| NIH project number | 5F31EY035168-02 |
| Project ID | NIH-10996105 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults diagnosed with diabetic retinopathy who require monitoring and treatment for their condition.
✕Less likely to help
Patients with other forms of retinal disease or those who do not have diabetic retinopathy may not benefit from this research.
What this research studies
This research focuses on enhancing ophthalmic imaging methods to better diagnose and treat diabetic retinopathy (DR), a major cause of blindness in adults. The study aims to utilize advanced optical coherence tomography (OCT) to provide detailed, three-dimensional images of the retina, allowing for earlier detection of neurodegenerative changes associated with DR. By improving visualization of retinal layers, the research seeks to facilitate more effective and less invasive treatment options for patients. The approach includes non-invasive metrics to monitor disease progression and aims to reduce the need for repeat invasive procedures.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and more effective treatment options for diabetic retinopathy, potentially preventing vision loss.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for retinal diseases, indicating that this approach could yield significant advancements.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Narawane, Amit — Duke University
- Study coordinator: Narawane, Amit
Related research
Other NIH-funded projects on the same topics.
-
Integrative multi-omics to understand diabetic retinopathy
A doctor-scientist team will study blood markers and genetic signals to see why diabetic retinopathy happens and how it affects Hispanic/Latino people.
-
Smartphone retinal imaging for diabetic eye disease in Egypt
This project uses a low-cost smartphone camera and AI to find signs of diabetic eye damage in adults with diabetes in Egypt.
-
Retinal Cell Loss in Diabetic Retinopathy
This project looks at how mitochondrial problems and a specific kind of cell death called ferroptosis may cause retinal cells to die in people with diabetes-related eye disease.
-
Redox-triggered REDD1 blockers for diabetic retinopathy
A research project tests new ways to stop a stress protein (REDD1) from causing vision problems in people with diabetic retinopathy.
-
Ultrafast eye imaging to detect and track diabetic retinopathy
A doctor-science team is developing ultra-fast eye scans to better see tiny blood vessels in people with diabetic retinopathy, helping catch changes early and guide treatment.
-
Practical device to automatically track abnormal retinal blood vessel growth in diabetic eye disease
A new, easier-to-use imaging device aims to automatically detect and monitor abnormal retinal blood vessel growth in people with diabetic retinopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.